share_log

HC Wainwright & Co. Initiates Coverage On Ensysce Biosciences With Buy Rating, Announces Price Target of $9

Benzinga ·  Jul 3, 2023 06:10

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Ensysce Biosciences (NASDAQ:ENSC) with a Buy rating and announces Price Target of $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment